Clinical Trial Update: UBT251 Injection Phase II Study (Overweight or Obesity) [Phase 2]

View source ↗

Summary

Phase II study update for UBT251 injection in obesity/overweight. The trial is currently active but not recruiting, sponsored by The United Bio-Technology (Heng…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• UBT251

Snippet

Sponsor: The United Bio-Technology (Hengqin) Co., Ltd. | Conditions: Obesity &Amp; Overweight | Phase 2 | Status: ACTIVE_NOT_RECRUITING